Vivani Medical, Inc. (VANI)
NASDAQ: VANI · IEX Real-Time Price · USD
1.730
-0.070 (-3.89%)
At close: Apr 24, 2024, 4:00 PM
1.720
-0.010 (-0.58%)
After-hours: Apr 24, 2024, 7:26 PM EDT
Company Description
Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need.
It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals.
The company is headquartered in Emeryville, California.
Vivani Medical, Inc.
Country | United States |
Founded | 1998 |
IPO Date | Nov 19, 2014 |
Industry | Biotechnology |
Sector | Healthcare |
Employees | 44 |
CEO | Adam Mendelsohn Ph.D. |
Contact Details
Address: 1350 S. Loop Road Alameda, California 94502 United States | |
Phone | 818-833-5000 |
Website | vivani.com |
Stock Details
Ticker Symbol | VANI |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001266806 |
ISIN Number | US92854B1098 |
SIC Code | 3845 |
Key Executives
Name | Position |
---|---|
Adam Mendelsohn Ph.D. | Co-Founder, Chief Executive Officer and Director |
Brigid Ann Makes | Chief Financial Officer |
Truc Le M.B.A. | Chief Operations Officer |
Dr. Lisa E. Porter M.D. | Chief Medical Officer |
Donald Dwyer M.B.A. | Chief Business Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Apr 23, 2024 | 8-K | Current Report |
Apr 22, 2024 | S-3 | Registration statement under Securities Act of 1933 |
Mar 26, 2024 | 10-K | Annual Report |
Mar 26, 2024 | 8-K | Current Report |
Mar 6, 2024 | 8-K | Current Report |
Mar 5, 2024 | 8-K | Current Report |
Mar 5, 2024 | 424B5 | Filing |
Mar 5, 2024 | 144 | Filing |
Feb 28, 2024 | 8-K | Current Report |
Jan 10, 2024 | 8-K | Current Report |